Discover 521 paid clinical trials in Calgary, . Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Calgary runs one of the busiest research programs in western Canada, with hundreds of studies recruiting at any given time.The Arthur J.E. Child Comprehensive Cancer Centre opened in Calgary in October 2024, making cancer research the city's fastest-growing trial area. Roughly a third of Calgary's recruiting studies are in oncology, and the rest cluster around heart failure, kidney disease, and metabolic conditions, much of it run through the University of Calgary. The city is also unusual for the volume of paediatric research at Alberta Children's Hospital, so families often find studies here that are not available elsewhere in the province.
Filter
2
Filter results
Results: 521
WebMAP for Childhood Cancer Survivors
for
Chronic Pain, Survivorship, Childhood Cancer
Location: Calgary
Sponsor: University of Calgary
Sex: All
Age: 11 - 17
Code: NCT05241717
Recruiting
HCRN Core Data Project: Characterizing Patient Populations in the Hydrocephalus Clinical Research Network (HCRN)
for
Pediatric Hydrocephalus
Location: Calgary, Vancouver, Seattle WA, Salt Lake City UT,
Sponsor: University of Utah
Sex: All
Age: 0 - 18
Code: NCT00670735
Recruiting
Voronistat in Pediatric Patients With Drug Resistant Epilepsy
for
Refractory Epilepsy
Location: Calgary
Sponsor: University of Calgary
Sex: All
Age: 2 - 17
Code: NCT03894826
Phase 2, Recruiting
CHILDNEPH The Canadian Childhood Nephrotic Syndrome Study
Robotic Rehabilitation and Brain Stimulation for Children With Hemiparetic Cerebral Palsy
for
Hemiplegic Cerebral Palsy, Perinatal Stroke
Location: Calgary
Sponsor: University of Calgary
Sex: All
Age: 6 - 18
Code: NCT04233710
Phase 2, Recruiting
Digital Health Pathway for Children With Medical Complexity Requiring Tracheostomy
for
Tracheostomy
Location: Calgary, Edmonton
Sponsor: University of Alberta
Sex: All
Age: 0 - 18
Code: NCT06375369
Recruiting
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
Sponsor: Canadian Institute of Natural and Integrative Medicine
Sex: All
Age: 7 - 18
Code: NCT00672529
Phase 2, Recruiting
Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease
for
Sickle Cell Disease (SCD)
Location: Calgary, Winnipeg, Chicago IL, Indianapolis IN,
Sponsor: University of Rochester
Sex: All
Age: 3 - 20
Code: NCT06941389
Recruiting
CAPRI National Juvenile Idiopathic Arthritis Registry